Oncocyte Corporation announced that Ronnie Andrews will step down from his role as a director of the company's board of directors, effective December 1, 2022. In order to ensure a smooth transition effective as of December 2, 2022, and Mr. Andrews will continue to act a consultant until February 28, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.74 USD | +1.86% | +3.40% | +9.60% |
06-03 | Oncocyte Corporation Announces Promising Results in A Phase 2 Clinical Trial | CI |
05-30 | Oncocyte Corporation Announces Favorable Oncocyte Vitgraft Kidney Study Results | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.60% | 36.62M | |
-43.04% | 7.78B | |
+12.75% | 3.73B | |
-20.15% | 2.01B | |
-22.61% | 1.63B | |
+23.82% | 1.08B | |
+24.08% | 776M | |
-11.14% | 679M | |
-29.59% | 508M | |
-0.40% | 291M |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- OncoCyte Corporation Announces Step Down of Ronnie Andrews as Board of Directors, Effective December 1, 2022